fda warning letters glp-1 compounded september 2025 Moderna, Prime Medicine, UnitedHealth: Readout Newsletter Trends In FDA FY 2025

For patients who are unsure if GLP-1s are right for them, that lack of flexibility can make Hims feel like a gamble

DSIP primarily supports deep sleep and nervous system balance Epitalon focuses on circadian rhythm regulation and cellular longevity Choosing the most appropriate therapy depends on individual goals, whether the focus is improving sleep quality, regulating circadian rhythm, or supporting healthy aging.

However, this combination should only be used under the guidance of a licensed healthcare provider, who can evaluate your individual health profile and ensure safety and effectiveness

A licensed clinician evaluates eligibility before any prescription, and telehealth follow-up supports titration and side-effect management afterward

Semaglutide: should the media slim down its enthusiasm

FDA expanded its nationwide alert to consumers about tainted weight loss pills that contain undeclared, active pharmaceutical ingredients